Opportunity Information: Apply for CDC RFA GH13 1360
Apply for CDC RFA GH13 1360
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Technical Assistance for Strengthening of Blood Transfusion Services and Increasing Access to Safe Blood in India under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 28, 2013 and posted on Feb 28, 2013.
- Applicants must submit their applications by Apr 11, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $10,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- ELIGIBILITY INFORMATION Eligible Applicants Eligible applicants that can apply for this funding opportunity are listed below Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For profit organizations (other than small business) Small, minority, and women owned businesses Universities Colleges Research institutions Hospitals Community based organizations Faith based organizations Federally recognized or state recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) Non domestic (non U.S.) entity A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with Other Attachment Forms when submitting via www.grants.gov.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH13-1360) is a PEPFAR-supported cooperative agreement from the Centers for Disease Control and Prevention focused on strengthening Indias National Blood Transfusion Service so that safe, quality blood can reach patients quickly, including those in far flung and remote areas. The public health driver behind the award is HIV prevention through safer transfusion practices, with a clear headline target: reduce transfusion associated HIV transmission to below 0.5 percent. The program is framed as technical assistance that helps national systems and partners improve how blood is collected, stored, used, and monitored across the country, aligning closely with Indias National AIDS Control Programme (NACP) and the priorities of the National AIDS Control Organization (NACO).
The program strategy is built around four connected pillars designed to address the blood supply chain end to end. First, it prioritizes shifting the blood supply toward regular (repeat) voluntary non remunerated donors, with phased improvements in donor recruitment and retention. This reflects a widely used safety approach in transfusion services, since repeat voluntary donors are generally associated with lower risk profiles and more consistent screening and education. Second, it supports establishing blood storage centers within the primary health care system so blood is available closer to where emergencies happen, reducing delays for rural and hard to reach populations. Third, it aims to promote appropriate clinical use of whole blood, components, and blood products, recognizing that safer transfusion is not only about collecting blood safely but also about using it correctly, avoiding unnecessary transfusions, and encouraging component therapy where appropriate. Fourth, it invests in structured capacity building for the workforce involved in blood transfusion services, using organized training programs tailored to different staff cadres, which is critical for consistent adherence to standards, proper screening and testing workflows, storage and transport practices, and clinical interface.
Beyond these four pillars, the announcement emphasizes system strengthening priorities identified by NACO. These include improving technical and service quality standards, strengthening management structures, building effective partnership mechanisms, and enhancing monitoring and evaluation systems. A standout priority area called out explicitly is strengthening Quality Management Systems in Blood Banks (QMSBB). In practice, this points to a focus on standard operating procedures, documentation and recordkeeping, internal audits, corrective and preventive actions, staff competency assessment, equipment maintenance and calibration, external quality assessment participation, and continuous quality improvement across blood banks and associated storage sites. The intent is to make blood safety improvements durable and measurable rather than one time upgrades.
On the funding side, the opportunity is classified as discretionary funding and uses a cooperative agreement mechanism, which typically means CDC expects substantial involvement in program guidance, coordination, and oversight compared to a more hands off grant. The estimated total funding listed is 10,000,000, with an award ceiling of 2,000,000 and an award floor of 0, and the expected number of awards is 1. There is no cost sharing or matching requirement. The activity category is health, and the CFDA number is 93.067 (Global AIDS), placing it clearly within the PEPFAR and global HIV portfolio.
Eligibility is broad and includes many types of applicants: nonprofits with or without 501(c)(3) status, for profit organizations (other than small business), small and minority and women owned businesses, universities and colleges, research institutions, hospitals, community based and faith based organizations, tribal governments and tribal health organizations, and U.S. state and local governments or their bona fide agents, as well as non U.S. (non domestic) entities. The bona fide agent pathway is explicitly described as requiring a legal binding agreement from the relevant state or local government and submission of that documentation with the application package. This wide eligibility scope suggests CDC was seeking the strongest technically qualified implementer, regardless of organizational type, provided the applicant could credibly deliver national level technical assistance and coordinate with Indian government stakeholders and other development partners.
Key dates show this was posted on Feb 28, 2013, with an original and current closing date of Apr 11, 2013, and an archive date of May 11, 2013, meaning the competition is no longer open but the details remain useful as a reference model for similar blood safety and systems strengthening awards. For access issues with the full announcement, the listed contact was the CDC Procurement and Grants Office Technical Information Management Section (TIMS) via phone (770 488 2700) or email (pgotim@cdc.gov).
FAQs: CDC RFA GH13-1360 (Strengthening India's National Blood Transfusion Service)
What is CDC RFA GH13-1360 about?
CDC RFA GH13-1360 is a PEPFAR-supported cooperative agreement from the Centers for Disease Control and Prevention (CDC) focused on strengthening India's National Blood Transfusion Service so safe, quality blood can reach patients quickly, including people in far-flung and remote areas.
What public health problem is this opportunity designed to address?
The main public health driver is HIV prevention through safer transfusion practices. A headline target is to reduce transfusion-associated HIV transmission to below 0.5 percent.
How is the program positioned: direct service delivery or technical assistance?
The program is framed as technical assistance intended to help national systems and partners improve how blood is collected, stored, used, and monitored across India.
How does this opportunity align with India's national HIV response?
It aligns closely with India's National AIDS Control Programme (NACP) and the priorities of the National AIDS Control Organization (NACO), including system strengthening priorities identified by NACO.
What are the main technical focus areas (pillars) of the program?
The strategy is built around four connected pillars that address the blood supply chain end to end: (1) shifting the blood supply toward regular (repeat) voluntary non-remunerated donors; (2) establishing blood storage centers within the primary health care system; (3) promoting appropriate clinical use of whole blood, components, and blood products; and (4) structured capacity building for the blood transfusion workforce through organized training tailored to different staff cadres.
What does "shifting toward regular voluntary non-remunerated donors" mean in this context?
It means prioritizing a move toward repeat voluntary donors (rather than paid or one-time donors), with phased improvements in donor recruitment and retention. This reflects a common blood safety approach because repeat voluntary donors are generally associated with lower risk profiles and more consistent screening and education.
Why does the opportunity emphasize blood storage centers in primary health care?
The intent is to make blood available closer to where emergencies happen, reducing delays for rural and hard-to-reach populations and improving timely access.
What is meant by "appropriate clinical use" of blood and blood products?
It recognizes that safer transfusion is not only about collecting blood safely, but also about using it correctly by avoiding unnecessary transfusions and encouraging component therapy where appropriate.
What kind of workforce development does the opportunity describe?
It calls for structured capacity building using organized training programs tailored to different staff cadres involved in blood transfusion services, supporting consistent adherence to standards, proper screening and testing workflows, storage and transport practices, and the clinical interface.
Beyond the four pillars, what system strengthening priorities are highlighted?
The announcement emphasizes priorities identified by NACO, including improving technical and service quality standards, strengthening management structures, building effective partnership mechanisms, and enhancing monitoring and evaluation systems.
What is QMSBB and why is it a standout priority?
QMSBB refers to strengthening Quality Management Systems in Blood Banks. It is called out explicitly as a priority and points to durable, measurable improvements in how blood banks and storage sites manage quality, rather than one-time upgrades.
What activities are typically included under Quality Management Systems in Blood Banks (QMSBB) as described here?
The announcement points to elements such as standard operating procedures, documentation and recordkeeping, internal audits, corrective and preventive actions, staff competency assessment, equipment maintenance and calibration, participation in external quality assessment, and continuous quality improvement across blood banks and associated storage sites.
What type of funding mechanism is used?
This is a cooperative agreement, which typically means CDC expects substantial involvement in program guidance, coordination, and oversight compared to a more hands-off grant.
Is this considered discretionary funding?
Yes. The opportunity is classified as discretionary funding.
What is the total estimated funding amount?
The estimated total funding listed is 10,000,000.
What are the award ceiling and award floor?
The award ceiling is 2,000,000 and the award floor is 0.
How many awards were expected?
The expected number of awards is 1.
Is cost sharing or matching required?
No. There is no cost sharing or matching requirement stated for this opportunity.
What is the activity category for this funding opportunity?
The activity category is health.
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.067 (Global AIDS), placing it within the PEPFAR and global HIV portfolio.
Who was eligible to apply?
Eligibility is broad and includes: nonprofits with or without 501(c)(3) status; for-profit organizations (other than small business); small businesses and minority- and women-owned businesses; universities and colleges; research institutions; hospitals; community-based and faith-based organizations; tribal governments and tribal health organizations; U.S. state and local governments (or their bona fide agents); and non-U.S. (non-domestic) entities.
Are non-U.S. organizations eligible?
Yes. Non-U.S. (non-domestic) entities are included in the eligibility list.
What does "bona fide agent" mean for state or local government applicants?
The announcement describes a bona fide agent as an entity applying on behalf of a state or local government and notes that this pathway requires a legally binding agreement from the relevant state or local government. That documentation must be submitted with the application package.
When was this opportunity posted and when did it close?
It was posted on Feb 28, 2013. The original and current closing date is Apr 11, 2013.
Is the competition still open?
No. The archive date is May 11, 2013, indicating the competition is no longer open, though the details can still serve as a reference model for similar awards.
Who was the listed contact for access issues with the full announcement?
The listed contact was the CDC Procurement and Grants Office Technical Information Management Section (TIMS), reachable by phone at 770-488-2700 or by email at pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Establishment of a University Partnership with Kinnaird College for Women, Lahore, Pakistan in English and American Literature
Previous opportunity: Strengthening Human Resources for Health through Public Health Training Improvements at the Muhimbili University of Health and Allied Sciences (MUHAS), School of Public Health and Social Sciences (SPHSS) in the United Republic of Tanzania under PEPFA
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1360
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1360) also looked into and applied for these:
| Funding Opportunity |
|---|
| Supporting the implementation and capacity building of HIV/AIDS prevention interventions for youth using evidence based approaches in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1341 Funding Number: CDC RFA GH13 1341 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $6,000,000 |
| Accelerating Progress Against TB in Kenya (APA K) Apply for RFA 615 13 000003 Funding Number: RFA 615 13 000003 Agency: Kenya USAID Nairobi Category: Health Funding Amount: $40,000,000 |
| Genomes to Natural Products (U01) Apply for RFA GM 14 002 Funding Number: RFA GM 14 002 Agency: National Institutes of Health Category: Health Funding Amount: $2,250,000 |
| Investigator Initiated Multi Site Clinical Trials (Collaborative R01) Apply for PAR 13 128 Funding Number: PAR 13 128 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Alzheimers Disease Research Centers (P50) Apply for RFA AG 13 019 Funding Number: RFA AG 13 019 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Small Business Innovation Research on Rare Musculoskeletal, Rheumatic and Skin Diseases (SBIR) (R43) Apply for RFA AR 14 005 Funding Number: RFA AR 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Collaborations for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 004 Funding Number: RFA GM 14 004 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| Research Networks for Macromolecular Interactions in Cells (U54) Apply for RFA GM 14 005 Funding Number: RFA GM 14 005 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIH Directors Biomedical Research Workforce Innovation Award Broadening Experiences in Scientific Training (BEST) (DP7) Apply for RFA RM 12 022 Funding Number: RFA RM 12 022 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| NGO Health Service Delivery Program Apply for RFA 442 13 000001 Funding Number: RFA 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $6,600,000 |
| Advancing Eating Disorders Research through Dimensional Studies of Biology and Behavior (R01) Apply for RFA MH 14 030 Funding Number: RFA MH 14 030 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Program for Extramural/Intramural Alcohol Research Collaborations (U01) Apply for PAR 13 133 Funding Number: PAR 13 133 Agency: National Institutes of Health Category: Health Funding Amount: $250,000 |
| HIV Prevention with Key Populations Mali Apply for RFA 688 13 000004 Funding Number: RFA 688 13 000004 Agency: Mali USAID Bamako Category: Health Funding Amount: $2,000,000 |
| Supporting a Caribbean Regional Educational Institution to Deliver Leadership and Management Training to Health Professionals in Eleven Caribbean Partnership Framework Countries under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1348 Funding Number: CDC RFA GH13 1348 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Preclinical Innovation Program (PIP) (R01) Apply for RFA AI 13 008 Funding Number: RFA AI 13 008 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Mechanisms of Cellular Immunity in the Female Reproductive Tract (R01) Apply for RFA AI 12 054 Funding Number: RFA AI 12 054 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Planning Grants for the NIH National Research Mentoring Network (NRMN) (P20) Apply for RFA RM 13 002 Funding Number: RFA RM 13 002 Agency: National Institutes of Health Category: Health Funding Amount: $130,000 |
| Planning Grants for the NIH Building Infrastructure Leading to Diversity (BUILD) Initiative (P20) Apply for RFA RM 13 001 Funding Number: RFA RM 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| PsychENCODE Identification and Characterization of Non coding Functional Elements in the Brain, and their Role in the Development of Mental Disorders (R01) Apply for RFA MH 14 020 Funding Number: RFA MH 14 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dimensional Approaches to Research Classification in Psychiatric Disorders (R01) Apply for RFA MH 14 050 Funding Number: RFA MH 14 050 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1360", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.